Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Over-expression of CCK1 Receptor Reverse Morphine Dependence.

Hao L, Wen D, Gou H, Yu F, Cong B, Ma C.

Int J Pept Res Ther. 2018;24(3):471-477. doi: 10.1007/s10989-018-9696-7. Epub 2018 Apr 2.

2.

Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.

Wen D, Ma CL, Zhang YJ, Meng YX, Ni ZY, Li SJ, Cong B.

BMC Neurosci. 2012 Jun 8;13:63. doi: 10.1186/1471-2202-13-63.

3.

Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats.

Yu H, Wen D, Ma C, Meng Y, Li S, Ni Z, Cong B.

PLoS One. 2012;7(7):e41860. doi: 10.1371/journal.pone.0041860. Epub 2012 Jul 27.

4.

IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence.

Wu N, Su RB, Xu B, Lu XQ, Liu Y, Zheng JQ, Piletz JE, Li J, Qin BY.

Biochem Pharmacol. 2005 Oct 1;70(7):1079-87.

PMID:
16112088
5.

Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.

Wen D, Sun D, Zang G, Hao L, Liu X, Yu F, Ma C, Cong B.

Neuroscience. 2014 Sep 26;277:14-25. doi: 10.1016/j.neuroscience.2014.06.048. Epub 2014 Jun 30.

PMID:
24993476
6.

Hydrogen sulfide attenuates opioid dependence by suppression of adenylate cyclase/cAMP pathway.

Yang HY, Wu ZY, Wood M, Whiteman M, Bian JS.

Antioxid Redox Signal. 2014 Jan 1;20(1):31-41. doi: 10.1089/ars.2012.5119. Epub 2013 Jul 11.

7.
8.

CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation.

Langmesser S, Cerezo-Guisado MI, Lorenzo MJ, Garcia-Marin LJ, Bragado MJ.

J Cell Biochem. 2007 Mar 1;100(4):851-64.

PMID:
17226751
9.

Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients.

Marchal-Victorion S, Vionnet N, Escrieut C, Dematos F, Dina C, Dufresne M, Vaysse N, Pradayrol L, Froguel P, Fourmy D.

Pharmacogenetics. 2002 Jan;12(1):23-30.

PMID:
11773861
10.
11.

Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.

Navarro-Zaragoza J, Laorden ML, Milanés MV.

Addict Biol. 2017 Mar;22(2):342-353. doi: 10.1111/adb.12328. Epub 2015 Nov 24.

PMID:
26598419
12.

Modulation of agmatine on calcium signal in morphine-dependent CHO cells by activation of IRAS, a candidate for imidazoline I1 receptor.

Wu N, Su RB, Liu Y, Lu XQ, Zheng JQ, Cong B, Li J.

Eur J Pharmacol. 2006 Oct 24;548(1-3):21-8. Epub 2006 Jul 22.

PMID:
16962578
13.

Comparison of agmatine with moxonidine and rilmenidine in morphine dependence in vitro: role of imidazoline I(1) receptors.

Li F, Wu N, Su RB, Liu Y, Lu XQ, Li J.

Eur J Pharmacol. 2009 Jun 10;612(1-3):1-8. doi: 10.1016/j.ejphar.2009.03.077. Epub 2009 Apr 6.

PMID:
19356733
14.

Up-regulation of cholesterol absorption is a mechanism for cholecystokinin-induced hypercholesterolemia.

Zhou L, Yang H, Okoro EU, Guo Z.

J Biol Chem. 2014 May 9;289(19):12989-99. doi: 10.1074/jbc.M113.534388. Epub 2014 Apr 1.

15.
17.

Opioid-induced mitogen-activated protein kinase signaling in rat enteric neurons following chronic morphine treatment.

Duraffourd C, Kumala E, Anselmi L, Brecha NC, Sternini C.

PLoS One. 2014 Oct 10;9(10):e110230. doi: 10.1371/journal.pone.0110230. eCollection 2014.

19.

Modulation of miR-139-5p on chronic morphine-induced, naloxone-precipitated cAMP overshoot in vitro.

Cao DN, Shi JJ, Wu N, Li J.

Metab Brain Dis. 2018 Oct;33(5):1501-1508. doi: 10.1007/s11011-018-0257-8. Epub 2018 Jun 18.

PMID:
29916183

Supplemental Content

Support Center